GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.01−0.01 (-0.50%)
Close on Nov 17, 2026Market cap $14.81MP/E –Yield –
GeoVax Labs operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
GeoVax Labs's operating cash flow for the twelve months ending Jun 30, 2026 was -$18.37M. For fiscal 2025 it was -$21.47M. The highest annual figure on record is -$303.62K in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.47M | – |
| FY2024 | Dec 31, 2024 | -$24.68M | – |
| FY2023 | Dec 31, 2023 | -$25.17M | – |
| FY2022 | Dec 31, 2022 | -$19.03M | – |
| FY2021 | Dec 31, 2021 | -$11.20M | – |
| FY2020 | Dec 31, 2020 | -$2.75M | – |
| FY2019 | Dec 31, 2019 | -$1.40M | – |
| FY2018 | Dec 31, 2018 | -$1.54M | – |
| FY2017 | Dec 31, 2017 | -$1.69M | – |
| FY2016 | Dec 31, 2016 | -$1.95M | – |
| FY2015 | Dec 31, 2015 | -$2.71M | – |
| FY2014 | Dec 31, 2014 | -$2.25M | – |
| FY2013 | Dec 31, 2013 | -$1.69M | – |
| FY2012 | Dec 31, 2012 | -$2.44M | – |
| FY2011 | Dec 31, 2011 | -$303.62K | – |
| FY2010 | Dec 31, 2010 | -$2.44M | – |
| FY2009 | Dec 31, 2009 | -$1.43M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.66M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.54M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.96M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.21M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.33M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.97M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.75M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.30M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.68M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.10M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.04M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.76M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.06M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.80M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.83M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.33M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.68M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.63M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.26M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.62M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.54M | – |
| Q3 FY2020 | Sep 30, 2020 | -$283.13K | – |
| Q2 FY2020 | Jun 30, 2020 | -$566.87K | – |
| Q1 FY2020 | Mar 31, 2020 | -$358.62K | – |
| Q4 FY2019 | Dec 31, 2019 | -$280.76K | – |
| Q3 FY2019 | Sep 30, 2019 | -$343.93K | – |
| Q2 FY2019 | Jun 30, 2019 | -$456.45K | – |
| Q1 FY2019 | Mar 31, 2019 | -$317.36K | – |
| Q4 FY2018 | Dec 31, 2018 | -$501.54K | – |
| Q3 FY2018 | Sep 30, 2018 | -$279.73K | – |
| Q2 FY2018 | Jun 30, 2018 | -$380.19K | – |
| Q1 FY2018 | Mar 31, 2018 | -$381.57K | – |
| Q4 FY2017 | Dec 31, 2017 | -$448.44K | – |
| Q3 FY2017 | Sep 30, 2017 | -$478.77K | – |
| Q2 FY2017 | Jun 30, 2017 | -$429.15K | – |
| Q1 FY2017 | Mar 31, 2017 | -$332.10K | – |
| Q4 FY2016 | Dec 31, 2016 | -$368.44K | – |
| Q3 FY2016 | Sep 30, 2016 | -$403.26K | – |
See a number that looks wrong?